- Home
- MLYS vs DXYZ Comparison
MLYS vs DXYZ Comparison
Compare MLYS & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MLYS | DXYZ |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 363.6M |
| IPO Year | 2023 | 2024 |
Fundamental Metrics
Financial Performance| Metric | MLYS | DXYZ |
|---|---|---|
| Price | $38.20 | $27.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $46.40 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | N/A |
| Earning Date | 11-10-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.24 | N/A |
| 52 Week High | $47.65 | N/A |
Technical Indicators
Market Signals| Indicator | MLYS | DXYZ |
|---|---|---|
| Relative Strength Index (RSI) | 41.22 | 67.76 |
| Support Level | $37.61 | $25.15 |
| Resistance Level | $44.13 | $22.28 |
| Average True Range (ATR) | 2.11 | 1.11 |
| MACD | -0.66 | 0.73 |
| Stochastic Oscillator | 7.99 | 84.34 |
Price Performance
Historical ComparisonAbout MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About DXYZ Destiny Tech100 Inc. Common Stock
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.